DNA-based immunization produces Th1 immune responses to hepatitis delta virus in a mouse model

Hepatology

Volumn 32, Issue 1, 2000, Pages 104-110

  Huang, Yi Hsiang ^a,d   Wu, Jaw Ching ^a,b   Tao, Mi Hua ^e   Syu, Wan Jr ^c   Hsu, Sheng Chieh ^c   Chi, Wei Kuang ^f   Chang, Full Young ^a,d   Lee, Shou Dong ^a,d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b Institute of Clinical Medicine   (Taiwan)

^c Institute of Microbiology and Immunology   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^f DEVELOPMENT CENTER FOR BIOTECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS DELTA ANTIGEN; HEPATITIS VACCINE; INTERLEUKIN 2; INTERLEUKIN 4;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CYTOKINE RELEASE; DISEASE ASSOCIATION; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROCONVERSION; T LYMPHOCYTE ACTIVATION;

EID: 0034235880     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.8348     Document Type: Article

References (52)

1. 1. Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL, Purcell RH. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 1980;141:590-602.
2. 2. Wu JC, Chen PJ, Kuo MYP, Lee SD, Chen DS, Ting LP. Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line. J Virol 1991;65:1099-1104.
3. 3. Wu JC, Chen CH, Hou MC, Chen TZ, Lee SD, Lo KJ. Multiple viral infections as the most common cause of fulminant and subfulminant viral hepatitis in an endemic area for hepatitis B: application and limitations of polymerase chain reaction. HEPATOLOGY 1994;19:836-840.
4. 4. Rizzetto M, Verme G, Recchia S, Bonino F, Farci P, Arico S, Calzia R, et al. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med 1983;98:437-441.
5. 5. Govindarajan S, De Cock KM, Redeker AG. Natural course of delta superinfection in chronic hepatitis B virus-infected patients: histologic study with multiple liver biopsies. Gastroenterology 1986;6:640-644.
6. 6. Wu JC, Lee SD, Govindarajan S, Kung TW, Tsai YT, Lo KJ, Ting LP. Correlation of serum delta RNA with clinical course of acute delta virus superinfection in Taiwan: a longitudinal study. J Infect Dis 1990;161:1116-1120.
7. 7. Wu JC, Chen TZ, Huang YS, Yen FS, Ting LT, Sheng WY, Tsay SH, Lee SD. Natural history of hepatitis D viral superinfection - significance of viremia detected by polymerase chain reaction. Gastroenterology 1995; 108:796-802.
8. 8. Chang MH, Chen CJ, Lai MS, Hsu HS, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997;336:1855-1859.
9. 9. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995;13:29-60.
10. 10. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like T helper cells in hepatitis C virus (HCV) infection: implications for HCV chronicity. HEPATOLOGY 1997;25:449-458.
11. 11. Negro F, Rizzetto M. Pathobiology of hepatitis delta virus. J Hepatol 1993;17(Suppl 3):S149-S153.
12. 12. Guilhot S, Huang SN, Xia YP, La Minica N, Lai MMC, Chisari FV. Expression of hepatitis delta virus large and small antigens in transgenic mice. J Virol 1994;68:1052-1058.
13. 13. Nisini R, Paroli M, Accapezzato D, Bonino F, Rosina F, Santantonio T, Sallusto, et al. Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles. J Virol 1997;71:2241-2251.
14. 14. Farci P, Mandas A, Colana A, Lai ME, Desmet V, Eyken PV, Gibo Y, et al. Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med 1994;330:88-94.
15. 15. Yokoyama M, Zhang J, Whitton JL. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J Virol 1995;69:2684-2688.
16. 16. Martins LP, Lau LL, Asano MS, Ahmed R. DNA vaccination against persistent viral infection. J Virol 1995;69:2574-2582.
17. 17. Tokushige K, Wakita T, Pachuk C, Moradpour D, Weiner DB, Zurawaki Jr VR, Wands JR. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. HEPATOLOGY 1996;24:14-20.
18. 18. McDonnell WM, Askari FK. DNA vaccines. N Engl J Med 1996;334:42-45.
19. 19. Montgomery DL, Shiver JW, Leander KR, Perry HC, Friedman A, Martinez D, Ulmer JB, et al. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol 1993;12:777-783.
20. 20. Donelly JJ, Friedman A, Martinez D, Montgomery DL, Shiver JW, Motzel SL, Ulmer JB, et al. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat Med 1995;1:583-587.
21. 21. Manickan E, Rouse RJ, Yu Z, Wire WS, Rouse BT. Genetic immunization against herpes simplex virus: protection is mediated by CD4+ T lymphocytes. J Immunol 1995;155:259-265.
22. 22. Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 1994;199: 132-140.
23. 23. Yasutomi Y, Robinson HL, Lu S, Mustafa F, Lekutis C, Arthos J, Mullins JI, et al. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of Rhesus monkeys. J Virol 1996;70: 678-681.
24. 24. Wang B, Merva M, Dang K, Ugen KE, Boyer J, Willians WV, Weiner DB. DNA inoculation induced protective in vivo immune responses against cellular challenge with HIV-1 antigen-expressing cells. AIDS Res Hum Retroviruses 1994;4:S35-S41.
25. 25. Schirmback R, Bohm W, Ando K, Chisari FV, Reimann J. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J Virol 1995;69:5929-5934.
26. 26. Chow YH, Huang WL, Chi WK, Chu YD, Tao MH. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol 1997;71:169-178.
27. 27. Geissler M, Tokushige K, Chante CC, Zurawaski VR, Wands JR. Cellular and humoral immune response to hepatitis B virus structure proteins in mice after DNA-based immunization. Gastroenterology 1997;112:1307-1320.
28. 28. Geissler M, Schirmbeck R, Reimann J, Blum HE, Wands JR. Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice. HEPATOLOGY 1998;28:202-210.
29. 29. Lu M, Hilken G, Kruppenbacher J, Kemper T, Schirmbeck R, Reimann J, Roggendorf M. Immunization of woodchuck with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection. J Virol 1999;73:281-289.
30. 30. Rollier C, Sunyach C, Barraud L, Madani N, Jamard C, Trepo C, Cova L. Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein. Gastroenterology 1999;116:658-665.
31. 31. Major ME, Vitvitski L, Mink MA, Schleef M, Whalen RG, Trepo C, Inchauspe G. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J Virol 1995;69:5798-805.
32. 32. Saito T, Sherman GJ, Kurokohchi K, Guo ZP, Donets M, Yu MYW, Berzofsky JA, et al. Plasmid DNA-based immunization for hepatitis C virus structure proteins: immune responses in mice. Gastroenterology 1997;112:1321-1330.
33. 33. Fournillier A, Nakano I, Vitvitski L, Depla E, Vidalin O, Maertens G, Trepo C, et al. Modulation of immune responses to hepatitis C virus envelope E2 protein following injection of plasmid DNA using single or combined delivery routes. HEPATOLOGY 1998;28:237-244.
34. 34. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res 1982;42:3858-3863.
35. 35. Wu JC, Chen CL, Lee SD, Sheen IJ, Ting LP. Expression and localization of the small and large delta antigens during the replication cycle of hepatitis D virus. HEPATOLOGY 1992;16:1120-1127.
36. 36. Lee SC, Shew JY, Chang ACH. Monoclonal antibodies to hepatitis B surface antigen (HBsAg) produced by somatic cell hybrids. J Formosa Med Assoc 1984;83:143-148.
37. 37. Lin HP, Hsu SC, Wu JC, Sheen IJ, Yan BS, Syu WJ. Localization of isoprenylated antigen of hepatitis delta virus by anti-farnesyl antibodies. J Gen Virol 1999;80:91-96.
38. 38. Hsu SC, Yan BS, Pan JM, Syu WJ. A monoclonal antibody reacts with maltose-binding protein of Escherichia coli and related enteric bacteria. J Immunol Methods 1997;204:169-174.
39. 39. Chow YH, Chiang BL, Lee YL, Chi WK, Lin WC, Chen YT, Tao MH. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J Immunol 1998;160:1320-1329.
40. 40. Kruskal WH, Wallis WA. Use of ranks in one criterion variance analysis. J Am Stat Assoc 1952;47:583-621.
41. 41. Dunnett CW. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 1955;50:1096-1121.
42. 42. Mancini M, Hadchouel M, Davis HL, Whalen RG, Tiollais P, Michel ML. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc Natl Acad Sci U S A 1996;93:12496-12501.
43. 43. Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today 1991;12:256-257.
44. 44. Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 1992;10:385-409.
45. 45. Hassett DE, Zhang J, Whitton JL. Induction of antiviral antibodies by DNA immunization requires neither perforin-mediated nor CD8+-T-cell-mediated lysis of antigen-expressing cells. J Virol 1999;73:7870-7873.
46. 46. Hwang SB, Lai MMC. A unique conformation at the carboxyl terminus of the small hepatitis delta antigen revealed by a specific monoclonal antibody. Virology 1993;193:924-931.
47. 47. Hwang SB, Lai MMC. Isoprenylation masks a conformational epitope and enhances trans-dominant inhibitory function of the large hepatitis delta antigen. J Virol 1994;68:2958-2964.
48. 48. Karayiannis P, Saldanha J, Monjardino J, Goldin R, Main J, Luther S, Easton M, et al. Immunization of woodchucks with recombinant hepatitis delta antigen does not protect against hepatitis delta virus infection. HEPATOLOGY 1990;12:1125-1128.
49. 49. Karayiannis P, Saldanha J, Jackson AM, Luther S, Goldin R, Monjardino J, Thomas HC. Partial control of hepatitis delta virus superinfection by immunisation of woodchucks (Marmota monax) with hepatitis delta antigen expressed by a recombinant vaccinia or baculovirus. J Med Virol 1993;41:210-214.
50. 50. Roingeard P, Dubois F, Marcellin P, Bernuau J, Bonduelle S, Benhamou JP, Goudeau A. Persistent delta antigenemia in chronic delta hepatitis and its relation with human immunodeficiency virus infection. J Med Virol 1992;38:191-194.
51. 51. Franco A, Guidotti LG, Hobbs MV, Pasquetto V, Chisari FV. Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice. J Immunol 1997;59:2001-2008.
52. 52. Mancini M, Hadchouel M, Tiollais P, Michel ML. Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-γ-secreting T cells after DNA-based immunization. J Immunol 1998;161:5564-5570.